These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22019210)

  • 1. Bridging therapy after recent stent implantation: case report and review of data.
    Wessler JD; Saldana F; Giugliano RP
    Cardiovasc Revasc Med; 2012; 13(1):30-8. PubMed ID: 22019210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents.
    Ben Morrison T; Horst BM; Brown MJ; Bell MR; Daniels PR
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):575-82. PubMed ID: 22448399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature.
    Pickett AM; Taylor DA; Ackman ML
    Pharmacotherapy; 2010 Apr; 30(4):127e-33e. PubMed ID: 20334463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of eptifibatide as a bridge antiplatelet agent for intrathecal drug delivery system placement.
    Sisk J; Palma M; Cooper C; Eltahawy E; Atallah J
    Pain Physician; 2012; 15(6):479-83. PubMed ID: 23159964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies.
    Rossini R; Musumeci G; Visconti LO; Bramucci E; Castiglioni B; De Servi S; Lettieri C; Lettino M; Piccaluga E; Savonitto S; Trabattoni D; Capodanno D; Buffoli F; Parolari A; Dionigi G; Boni L; Biglioli F; Valdatta L; Droghetti A; Bozzani A; Setacci C; Ravelli P; Crescini C; Staurenghi G; Scarone P; Francetti L; D'Angelo F; Gadda F; Comel A; Salvi L; Lorini L; Antonelli M; Bovenzi F; Cremonesi A; Angiolillo DJ; Guagliumi G; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    EuroIntervention; 2014 May; 10(1):38-46. PubMed ID: 24832636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration.
    Alshawabkeh LI; Prasad A; Lenkovsky F; Makary LF; Kandil ES; Weideman RA; Kelly KC; Rangan BV; Banerjee S; Brilakis ES
    EuroIntervention; 2013 Jun; 9(2):204-11. PubMed ID: 23454910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging with GP IIb/IIIa inhibitors after abdominal surgery in a patient presenting with late stent thrombosis of a drug-eluting stent and who cannot receive oral antiplatelet treatment.
    Ben-Dor I; Waksman R
    J Invasive Cardiol; 2009 Apr; 21(4):E73-6. PubMed ID: 19342766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging Experience With Eptifibatide After Stent Implantation.
    Barra ME; Fanikos J; Gerhard-Herman MD; Bhatt DL
    Crit Pathw Cardiol; 2016 Sep; 15(3):82-8. PubMed ID: 27465001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
    Biondi-Zoccai GG; Valgimigli M; Sheiban I; Margheri M; Marzocchi A; Prati F; Vischi M; Lettieri C; Violini R; Sardella G; Stabile A; Clementi F; Romeo F; Colombo A; Sangiorgi G
    J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):957-62. PubMed ID: 18695440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.
    Khair T; Garcia B; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2011; 12(2):99-104. PubMed ID: 21421188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].
    Rossini R; Bramucci E; Castiglioni B; De Servi S; Lettieri C; Lettino M; Musumeci G; Visconti LO; Piccaluga E; Savonitto S; Trabattoni D; Buffoli F; Angiolillo DJ; Bovenzi F; Cremonesi A; Scherillo M; Guagliumi G; ;
    G Ital Cardiol (Rome); 2012; 13(7-8):528-51. PubMed ID: 22781382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
    Feldman DN; Wong SC; Bergman G; Minutello RM
    J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging therapy in the perioperative management of patients with drug-eluting stents.
    Chou S; Eshaghian S; Lamer A; Tran H; Dohad S; Kaul S
    Rev Cardiovasc Med; 2009; 10(4):209-18. PubMed ID: 20065931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial.
    Tcheng JE; Lim IH; Srinivasan S; Jozic J; Gibson CM; O'Shea JC; Puma JA; Simon DI
    Circ Cardiovasc Interv; 2009 Feb; 2(1):43-51. PubMed ID: 20031692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery.
    Rassi AN; Blackstone E; Militello MA; Theodos G; Cavender MA; Sun Z; Ellis SG; Cho L
    Am J Cardiol; 2012 Aug; 110(4):485-90. PubMed ID: 22591672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perioperative management of patients with drug-eluting coronary stents presenting for non-cardiac surgery].
    Arai F; Kita T; Sasaki S
    Masui; 2008 Jul; 57(7):879-85. PubMed ID: 18649644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; results from the ESPRIT trial.
    Dery JP; Campbell ME; Mathias J; Pieper KS; Harrington RA; Madan M; Gibson CM; Tolleson TR; O'Shea JC; Tcheng JE;
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):43-50. PubMed ID: 17203469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.
    Akkus NI; Rajpal S; Agnani S
    J Invasive Cardiol; 2012 Feb; 24(2):76-8. PubMed ID: 22294539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
    Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
    Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
    Teirstein PS; Kao J; Watkins M; Tannenbaum MA; Laufer N; Chang M; Mehran R; Dangas G; Russell ME; Ellis SG; Stone GW
    Am J Cardiol; 2005 Aug; 96(4):500-5. PubMed ID: 16098300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.